Search
Feed aggregator
Bavarian Nordic’s Mpox Vaccine Safe, Effective at Lower Doses: Study
Bavarian Nordic’s Mpox Vaccine Safe, Effective at Lower Doses: Study 4/29/2024
Safety Concerns with MorphoSys’ Blood Cancer Drug Could Mar $2.9B Novartis Buy: STAT
Safety Concerns with MorphoSys’ Blood Cancer Drug Could Mar $2.9B Novartis Buy: STAT 4/29/2024
Pharma R&D ROI Spikes in 2023 as ‘Breakthroughs’ Re-Energize Industry: Report
Pharma R&D ROI Spikes in 2023 as ‘Breakthroughs’ Re-Energize Industry: Report 4/29/2024
What’s Next for Obesity Therapeutics? Higher Quality Weight Loss
What’s Next for Obesity Therapeutics? Higher Quality Weight Loss 4/29/2024
As Autism Cases Rise, Biopharma Springs Into Action
As Autism Cases Rise, Biopharma Springs Into Action 4/29/2024
5 Mid-Stage ALS Drugs to Watch
5 Mid-Stage ALS Drugs to Watch 4/29/2024
Opinion: Larimar Could Compete with Biogen in Friedreich’s Ataxia
Opinion: Larimar Could Compete with Biogen in Friedreich’s Ataxia 4/29/2024
AbbVie Raises 2024 Profit Outlook, Reports Strong Q1 Sales for Skyrizi and Rinvoq
AbbVie Raises 2024 Profit Outlook, Reports Strong Q1 Sales for Skyrizi and Rinvoq 4/26/2024
Pfizer Secures FDA Approval for Hemophilia B Gene Therapy, Launches Warranty
Pfizer Secures FDA Approval for Hemophilia B Gene Therapy, Launches Warranty 4/26/2024
Gilead Touts 5% Revenue Jump, Positions for 2024 Growth and Culls Pipeline
Gilead Touts 5% Revenue Jump, Positions for 2024 Growth and Culls Pipeline 4/26/2024
GSK Sues Pfizer and BioNTech Over Alleged COVID-19 Patent Infringement
GSK Sues Pfizer and BioNTech Over Alleged COVID-19 Patent Infringement 4/26/2024
Cigna’s Evernorth to Offer Humira Biosimilar with No Out-of-Pocket Cost
Cigna’s Evernorth to Offer Humira Biosimilar with No Out-of-Pocket Cost 4/26/2024
BMS Decision to Lay Off 2,200 Employees Comes After M&A Spending Spree
BMS Decision to Lay Off 2,200 Employees Comes After M&A Spending Spree 4/26/2024
Tessera Cuts Dozens of Jobs Following Positive Preclinical Results
Tessera Cuts Dozens of Jobs Following Positive Preclinical Results 4/26/2024
BMS to Cut 2,200 Jobs in $1.5B Restructuring as Opdivo Sales Drop in Q1
BMS to Cut 2,200 Jobs in $1.5B Restructuring as Opdivo Sales Drop in Q1 4/25/2024
Merck Gets Q1 Beat as Sales of Cancer Blockbuster Keytruda Jump 20%
Merck Gets Q1 Beat as Sales of Cancer Blockbuster Keytruda Jump 20% 4/25/2024
Sanders Launches Probe of ‘Outrageously High Prices’ of Novo’s Ozempic, Wegovy
Sanders Launches Probe of ‘Outrageously High Prices’ of Novo’s Ozempic, Wegovy 4/25/2024
Regeneron Pays Mammoth $100M to Access CRISPR Enzymes for AAV Delivery
Regeneron Pays Mammoth $100M to Access CRISPR Enzymes for AAV Delivery 4/25/2024
Sanofi and AstraZeneca Scrap Several Early-Stage Programs in Q1
Sanofi and AstraZeneca Scrap Several Early-Stage Programs in Q1 4/25/2024
FTC’s Noncompete Ban Makes Switching Biopharma Jobs Easier
FTC’s Noncompete Ban Makes Switching Biopharma Jobs Easier 4/25/2024
World Pharma News
- 3D experimental system to evaluate candidate drugs against glioma
- New drug combination doubles down on Alzheimer's treatments
- A small molecule drug candidate fully restores survival in a lethal mouse model of a rare kidney stone disease
- Scientists discover the antibacterial potential of ‘hero’ Korean skincare ingredient
- Bristol Myers Squibb evolves and expands Standing in the Gaap to advance more equitable care in multiple myeloma